About this Report
2008 has been extremely beneficial for the Rx-to-OTC reclassification process. A number of unique products has entered the market at the same time as unprecedented EU-wide switching is taking place. This report examines the impact on OTC healthcare and reviews how switches and reverse switches affect mature categories such as analgesics, digestive remedies and cough, cold and allergy remedies, and emerging ones such as statins, triptans and obesity.
What this report includes
- Up-to-the minute analysis of the latest trends in the industry
- New product development, forecasts and other themes
- Unique graphics and illustrated case studies
- Most recent brand and company news
- New insight into the size and shape of the market
Why buy this report
- Clear, concise powerpoint format makes it easy to digest
- Leading industry opinion keeps you abreast of latest news and trends
- Forward-looking outlook on a category, market or issue affecting the industry
- Latest five year forecasts assess how the market is predicted to develop
- Understand the competitive environment, the leading players and brands
Delivery format
PDF/PPT
Downloadable from MyPages
